- Joined
- Mar 12, 2002
- Messages
- 4,408
Hello and welcome,
Take the survey HERE
By taking part in this year's Global Drug Survey, you will be part of the biggest survey of drug use patterns in the world. Last year almost 80,000 took part in GDS2014. Our target this year, with media partners in 19 countries and with the survey having been translated into 12 languages is 120,000. That’s a lot of experience, expertise and opinion to share.
The survey is anonymous and confidential: We ask about your age gender and location to help us prepare meaningful reports so we can compare patterns of drug use across the world and provide our media partners with the correct information about local patterns of use.
Based on feedback from GDS2014, this year’s survey focuses on the following areas: performance enhancing drugs, cognitive enhancers, the darknet, safer drugs using limits, new forms of cannabis, prescription drug use, why people stop using drugs, new drug trends, the internet and of course alcohol and tobacco.
By taking part you consent for your information to be used by GDS in the preparation of its reports, health promotion activities and academic publications. You may withdraw your participation at any time and your data will not be submitted till the end of the survey.
As always we will ensure that you are the first to see the results through exclusive reports provided to our media partners who this year span Europe, the USA and Australasia.
Thank you once again for taking part this year – we’ll get back to you with the result in March/April 2015.
Have a happy and safe 2015
Dr Adam R Winstock
Founder Global Drug Survey
On behalf of the global GDS team
For further information please check our website or contact me at [email protected]
Global Drug Survey is an independent drug use data-mapping agency, based in London.
This research has received approval from the South London and Maudsley NHS Trust and Institute of Psychiatry Joint Ethics Committee, London England, and by The Ethics Committee of the Philosophical Faculty of the University of Zurich.
Take the survey HERE
By taking part in this year's Global Drug Survey, you will be part of the biggest survey of drug use patterns in the world. Last year almost 80,000 took part in GDS2014. Our target this year, with media partners in 19 countries and with the survey having been translated into 12 languages is 120,000. That’s a lot of experience, expertise and opinion to share.
The survey is anonymous and confidential: We ask about your age gender and location to help us prepare meaningful reports so we can compare patterns of drug use across the world and provide our media partners with the correct information about local patterns of use.
Based on feedback from GDS2014, this year’s survey focuses on the following areas: performance enhancing drugs, cognitive enhancers, the darknet, safer drugs using limits, new forms of cannabis, prescription drug use, why people stop using drugs, new drug trends, the internet and of course alcohol and tobacco.
By taking part you consent for your information to be used by GDS in the preparation of its reports, health promotion activities and academic publications. You may withdraw your participation at any time and your data will not be submitted till the end of the survey.
As always we will ensure that you are the first to see the results through exclusive reports provided to our media partners who this year span Europe, the USA and Australasia.
Thank you once again for taking part this year – we’ll get back to you with the result in March/April 2015.
Have a happy and safe 2015
Dr Adam R Winstock
Founder Global Drug Survey
On behalf of the global GDS team
For further information please check our website or contact me at [email protected]
Global Drug Survey is an independent drug use data-mapping agency, based in London.
This research has received approval from the South London and Maudsley NHS Trust and Institute of Psychiatry Joint Ethics Committee, London England, and by The Ethics Committee of the Philosophical Faculty of the University of Zurich.
Last edited by a moderator:
